New drug approval process

New Drug Approval Process FDA CDER (Center for Drug Evaluation and Research) Clinical Trials

Reasons for Medication Use ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Developing New Medicines Overview

Clinical Trials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Discovery/Pre-Clinical Testing ,[object Object],[object Object],[object Object],[object Object]

PHASE I (file IND ) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

PHASE II ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Phase III ,[object Object],[object Object],[object Object],[object Object],[object Object]

FDA Phase IV ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

11-12 yr left on patient Medication Available to patients

Generic Medications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],What’s in a Name?~~

The Name Game ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Similar Names Error Reduction ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Summary Slide ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

New drug approval process

Recomendados

Recomendados

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Destacado

Destacado (20)

Similar a New drug approval process

Similar a New drug approval process (20)

Más de Diana Rangaves, PharmD, CEO

Más de Diana Rangaves, PharmD, CEO (20)

Último

Último (20)

New drug approval process